1. Imidazoline- and Benzamidine-Based Trypanosome Alternative Oxidase Inhibitors: Synthesis and Structure-Activity Relationship Studies
- Author
-
Ministerio de Ciencia, Innovación y Universidades (España), European Commission, Japan Society for the Promotion of Science, Cisneros, David, Cueto-Díaz, Eduardo J., Medina-Gil, T., Chevillard, R., Bernal-Fraile, T., López-Sastre, R., Aldfer, M. M., Ungogo, M. A., Elati, H. A. A., Arai, N., Otani, M., Matsushiro, S., Kojima, C., Ebiloma, Godwin U., Shiba, T., De Koning, H. P., Dardonville, Christophe, Ministerio de Ciencia, Innovación y Universidades (España), European Commission, Japan Society for the Promotion of Science, Cisneros, David, Cueto-Díaz, Eduardo J., Medina-Gil, T., Chevillard, R., Bernal-Fraile, T., López-Sastre, R., Aldfer, M. M., Ungogo, M. A., Elati, H. A. A., Arai, N., Otani, M., Matsushiro, S., Kojima, C., Ebiloma, Godwin U., Shiba, T., De Koning, H. P., and Dardonville, Christophe
- Abstract
The trypanosome alternative oxidase (TAO), a mitochondrial enzyme involved in the respiration of the bloodstream form trypomastigotes of Trypanosoma brucei, is a validated drug target against African trypanosomes. Earlier series of TAO inhibitors having a 2,4-dihydroxy-6-methylbenzoic acid scaffold ("head") and a triphenylphosphonium or quinolin-1-ium cation as a mitochondrion-targeting group ("tail") were shown to be nanomolar inhibitors in enzymatic and cellular assays. We investigated here the effect of different mitochondrion-targeting cations and other scaffold modifications on the in vitro activity of this class of inhibitors. Low micromolar range activities were obtained, and the structure-activity relationship studies showed that modulation of the tail region with polar substituents is generally detrimental to the enzymatic and cellular activity of TAO inhibitors.
- Published
- 2022